Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces.

Deligiorgi, Maria V; Liapi, Charis; Trafalis, Dimitrios T

Deligiorgi, Maria V; Liapi, Charis; Trafalis, Dimitrios T.

Afiliação

Deligiorgi MV; Department of Pharmacology-Clinical Pharmacology Unit, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Liapi C; Department of Pharmacology-Clinical Pharmacology Unit, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Trafalis DT; Department of Pharmacology-Clinical Pharmacology Unit, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.

Expert Opin Biol Ther ; 21(8): 1097-1120, 2021 08.

Article em En | MEDLINE | ID: mdl-33393372

Assuntos

Antineoplásicos Imunológicos; Hipofisite; Neoplasias; Anticorpos Monoclonais/efeitos adversos; Antineoplásicos Imunológicos/efeitos adversos; Antígeno B7-H1; Antígeno CTLA-4; Humanos; Hipofisite/induzido quimicamente; Inibidores de Checkpoint Imunológico; Imunoterapia/efeitos adversos; Neoplasias/tratamento farmacológico

Palavras-chave

Anti-CTLA-4 monoclonal antibodies; anti-PD-L1 monoclonal antibodies; anti-PD1 monoclonal antibodies; immune-checkpoint inhibitors; immune-related central diabetes insipidus; immune-related hypophysitis; immune-related isolated ACTH deficiency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipofisite / Antineoplásicos Imunológicos / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Expert Opin Biol Ther Assunto da revista: BIOLOGIA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google